Microbot Medical Stock Market Value
MBOT Stock | USD 0.97 0.02 2.02% |
Symbol | Microbot |
Microbot Medical Price To Book Ratio
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Microbot Medical. If investors know Microbot will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Microbot Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.79) | Return On Assets (0.65) | Return On Equity (1.34) |
The market value of Microbot Medical is measured differently than its book value, which is the value of Microbot that is recorded on the company's balance sheet. Investors also form their own opinion of Microbot Medical's value that differs from its market value or its book value, called intrinsic value, which is Microbot Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Microbot Medical's market value can be influenced by many factors that don't directly affect Microbot Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Microbot Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Microbot Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Microbot Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Microbot Medical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Microbot Medical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Microbot Medical.
05/09/2023 |
| 11/29/2024 |
If you would invest 0.00 in Microbot Medical on May 9, 2023 and sell it all today you would earn a total of 0.00 from holding Microbot Medical or generate 0.0% return on investment in Microbot Medical over 570 days. Microbot Medical is related to or competes with Intuitive Surgical, Predictive Oncology, STAAR Surgical, Becton Dickinson, West Pharmaceutical, ResMed, and GlucoTrack. Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of roboti... More
Microbot Medical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Microbot Medical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Microbot Medical upside and downside potential and time the market with a certain degree of confidence.
Downside Deviation | 2.97 | |||
Information Ratio | (0.03) | |||
Maximum Drawdown | 15.87 | |||
Value At Risk | (4.60) | |||
Potential Upside | 5.38 |
Microbot Medical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Microbot Medical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Microbot Medical's standard deviation. In reality, there are many statistical measures that can use Microbot Medical historical prices to predict the future Microbot Medical's volatility.Risk Adjusted Performance | 0.0147 | |||
Jensen Alpha | (0.02) | |||
Total Risk Alpha | (0.44) | |||
Sortino Ratio | (0.03) | |||
Treynor Ratio | 0.0499 |
Microbot Medical Backtested Returns
Microbot Medical appears to be unstable, given 3 months investment horizon. Microbot Medical has Sharpe Ratio of 0.0725, which conveys that the firm had a 0.0725% return per unit of risk over the last 3 months. We have found thirty technical indicators for Microbot Medical, which you can use to evaluate the volatility of the firm. Please exercise Microbot Medical's Downside Deviation of 2.97, mean deviation of 2.13, and Risk Adjusted Performance of 0.0147 to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Microbot Medical holds a performance score of 5. The company secures a Beta (Market Risk) of 0.37, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, Microbot Medical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Microbot Medical is expected to be smaller as well. Please check Microbot Medical's jensen alpha, skewness, relative strength index, as well as the relationship between the value at risk and day median price , to make a quick decision on whether Microbot Medical's current price movements will revert.
Auto-correlation | 0.28 |
Poor predictability
Microbot Medical has poor predictability. Overlapping area represents the amount of predictability between Microbot Medical time series from 9th of May 2023 to 18th of February 2024 and 18th of February 2024 to 29th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Microbot Medical price movement. The serial correlation of 0.28 indicates that nearly 28.0% of current Microbot Medical price fluctuation can be explain by its past prices.
Correlation Coefficient | 0.28 | |
Spearman Rank Test | 0.53 | |
Residual Average | 0.0 | |
Price Variance | 0.01 |
Microbot Medical lagged returns against current returns
Autocorrelation, which is Microbot Medical stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Microbot Medical's stock expected returns. We can calculate the autocorrelation of Microbot Medical returns to help us make a trade decision. For example, suppose you find that Microbot Medical has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
Timeline |
Microbot Medical regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Microbot Medical stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Microbot Medical stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Microbot Medical stock over time.
Current vs Lagged Prices |
Timeline |
Microbot Medical Lagged Returns
When evaluating Microbot Medical's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Microbot Medical stock have on its future price. Microbot Medical autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Microbot Medical autocorrelation shows the relationship between Microbot Medical stock current value and its past values and can show if there is a momentum factor associated with investing in Microbot Medical.
Regressed Prices |
Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Microbot Stock Analysis
When running Microbot Medical's price analysis, check to measure Microbot Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Microbot Medical is operating at the current time. Most of Microbot Medical's value examination focuses on studying past and present price action to predict the probability of Microbot Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Microbot Medical's price. Additionally, you may evaluate how the addition of Microbot Medical to your portfolios can decrease your overall portfolio volatility.